BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1668887)

  • 1. Transgenic models of human cancer.
    Hinrichs SH; Fontes JD; Bills ND; Schneider PD
    Princess Takamatsu Symp; 1991; 22():259-74. PubMed ID: 1668887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse models of human gastric and hepatic carcinomas.
    Ullrich SJ; Zeng ZZ; Jay G
    Semin Cancer Biol; 1994 Feb; 5(1):61-8. PubMed ID: 8186389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spatio-temporal control of oncogenesis].
    Giovannini M
    Pathol Biol (Paris); 1998 Feb; 46(2):120-1. PubMed ID: 9769926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.
    Hasegawa H; Sawa H; Lewis MJ; Orba Y; Sheehy N; Yamamoto Y; Ichinohe T; Tsunetsugu-Yokota Y; Katano H; Takahashi H; Matsuda J; Sata T; Kurata T; Nagashima K; Hall WW
    Nat Med; 2006 Apr; 12(4):466-72. PubMed ID: 16550188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dissection of multi-stage tumorigenesis in transgenic mice.
    Christofori G; Hanahan D
    Semin Cancer Biol; 1994 Feb; 5(1):3-12. PubMed ID: 8186386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transgenic mice and their use in cancer study].
    Yamamura K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):733-9. PubMed ID: 2496665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
    Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
    Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncogenesis in transgenic mice].
    Shvemberger IN; Ermilov AN
    Tsitologiia; 1994; 36(2):131-47. PubMed ID: 7809963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary tumorigenesis and metastasis in transgenic mice.
    Webster MA; Muller WJ
    Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches for modelling cancer mechanisms in the mouse.
    Maddison K; Clarke AR
    J Pathol; 2005 Jan; 205(2):181-93. PubMed ID: 15641017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathological and molecular analyses of mammary tumors induced in HTLV-I pX transgenic rats].
    Yamada S
    Hokkaido Igaku Zasshi; 1994 May; 69(3):479-91, 493, 495-7. PubMed ID: 7927176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transgenic mouse model for mammary carcinogenesis.
    Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
    Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse models for the prevention of breast cancer.
    Shen Q; Brown PH
    Mutat Res; 2005 Aug; 576(1-2):93-110. PubMed ID: 15888345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse models of human breast cancer.
    Hutchinson JN; Muller WJ
    Oncogene; 2000 Dec; 19(53):6130-7. PubMed ID: 11156526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary gland neoplasia: insights from transgenic mouse models.
    Siegel PM; Hardy WR; Muller WJ
    Bioessays; 2000 Jun; 22(6):554-63. PubMed ID: 10842309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM; Shackleford GM
    Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.
    Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):555-63. PubMed ID: 12050097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.